149 related articles for article (PubMed ID: 11874387)
21. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
[TBL] [Abstract][Full Text] [Related]
22. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
[TBL] [Abstract][Full Text] [Related]
23. Orally administered nifedipine in chronic stable asthma. Comparison with an orally administered sympathomimetic.
Schwartzstein RS; Fanta CH
Am Rev Respir Dis; 1986 Aug; 134(2):262-5. PubMed ID: 3740651
[TBL] [Abstract][Full Text] [Related]
24. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
[TBL] [Abstract][Full Text] [Related]
25. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
26. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
[TBL] [Abstract][Full Text] [Related]
27. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
28. Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study.
Zanolla L; Franceschini L; Rossi L; Ochan M; Amigoni S; Zardini P
Br J Clin Pract Suppl; 1997 Apr; 88():27-35. PubMed ID: 9519505
[TBL] [Abstract][Full Text] [Related]
29. Nifedipine in chronic bronchial asthma: a randomized double-blind crossover trial against placebo.
Ozenne G; Moore ND; Leprevost A; Tardif C; Boismare F; Pasquis P; Lemercier JP
Eur J Respir Dis; 1985 Oct; 67(4):238-43. PubMed ID: 3908132
[TBL] [Abstract][Full Text] [Related]
30. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.
Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M
Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651
[TBL] [Abstract][Full Text] [Related]
31. Update on calcium-channel blocking agents.
Talbert RL; Bussey HI
Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
[TBL] [Abstract][Full Text] [Related]
32. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
33. Influence of diltiazem on bronchoconstriction induced by cold air breathing during exercise.
Magnussen H; Hartmann V; Reuss G
Thorax; 1984 Aug; 39(8):579-82. PubMed ID: 6382673
[TBL] [Abstract][Full Text] [Related]
34. Calcium channel blockers and terbutaline--a positive interaction.
Sharma TN; Gulati R; Gupta PR; Goyal RL; Gupta SD; Bhatnagar M
Indian J Chest Dis Allied Sci; 1990; 32(4):209-14. PubMed ID: 2134232
[TBL] [Abstract][Full Text] [Related]
35. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel blockers for lung function improvement in asthma: A systematic review and meta-analysis.
Chiu KY; Li JG; Lin Y
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):518-523.e3. PubMed ID: 29032888
[TBL] [Abstract][Full Text] [Related]
37. Comparison of nifedipine with a new calcium channel blocker, flordipine, in exercise-induced asthma.
Gordon EH; Wong SC; Klaustermeyer WB
J Asthma; 1987; 24(5):261-5. PubMed ID: 3327854
[TBL] [Abstract][Full Text] [Related]
38. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
40. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
